APO RESEARCH · REPORT
Carbocisteine
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. In this report, we study the Carbocisteine API.
Product & engineering
Understand the product.
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. In this report, we study the Carbocisteine API.
Selected research
Industry Research
Carbocisteine Industry Research Report 2026
Market perspective
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. In this report, we study the Carbocisteine API.
Global Carbocisteine key players include Moehs Iberica, Wuhan Grand Hoyo, Afton Pharma, Jinshi Pharm, Globe Quimica, etc. Global top five manufacturers hold a share about 60%. China is the largest sale market, with a share over 40%, followed by India, with a share about 30 percent. In terms of product, Above 98.50% is the largest segment, with a share about 75%. And in terms of application, the largest application is Tablet & Capsule, followed by Oral Solution.
Report Scope
Read the full market overview
This report quantifies the global Carbocisteine market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Carbocisteine.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Carbocisteine Market by Company
Wuhan Grand Hoyo
Moehs Iberica
Afton Pharma
Jinshi Pharm
Hengkang Pharma
Globe Quimica
Xiangyu Pharmaceutical
Carbocisteine Segment by Type
0.985
Above 98.50%
Carbocisteine Segment by Application
Oral Solution
Tablet & Capsule
Others
Carbocisteine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbocisteine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Carbocisteine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbocisteine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Carbocisteine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Carbocisteine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Carbocisteine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.985
- Above 98.50%
Applications
- Oral Solution
- Tablet & Capsule
- Others
Companies covered
- Wuhan Grand Hoyo
- Moehs Iberica
- Afton Pharma
- Jinshi Pharm
- Hengkang Pharma
- Globe Quimica
- Xiangyu Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Carbocisteine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 0.985
- 2.2.3 Above 98.50%
- 2.3 Carbocisteine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Solution
- 2.3.3 Tablet & Capsule
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Carbocisteine Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Carbocisteine Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Carbocisteine Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Carbocisteine Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Carbocisteine Production by Manufacturers (2021-2026)
- 3.2 Global Carbocisteine Production Value by Manufacturers (2021-2026)
- 3.3 Global Carbocisteine Average Price by Manufacturers (2021-2026)
- 3.4 Global Carbocisteine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Carbocisteine Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Carbocisteine Manufacturers, Product Type & Application
- 3.7 Global Carbocisteine Manufacturers Established Date
- 3.8 Global Carbocisteine Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Grand Hoyo
- 4.1.1 Wuhan Grand Hoyo Carbocisteine Company Information
- 4.1.2 Wuhan Grand Hoyo Carbocisteine Business Overview
- 4.1.3 Wuhan Grand Hoyo Carbocisteine Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Wuhan Grand Hoyo Product Portfolio
- 4.1.5 Wuhan Grand Hoyo Recent Developments
- 4.2 Moehs Iberica
- 4.2.1 Moehs Iberica Carbocisteine Company Information
- 4.2.2 Moehs Iberica Carbocisteine Business Overview
- 4.2.3 Moehs Iberica Carbocisteine Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Moehs Iberica Product Portfolio
- 4.2.5 Moehs Iberica Recent Developments
- 4.3 Afton Pharma
- 4.3.1 Afton Pharma Carbocisteine Company Information
- 4.3.2 Afton Pharma Carbocisteine Business Overview
- 4.3.3 Afton Pharma Carbocisteine Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Afton Pharma Product Portfolio
- 4.3.5 Afton Pharma Recent Developments
- 4.4 Jinshi Pharm
- 4.4.1 Jinshi Pharm Carbocisteine Company Information
- 4.4.2 Jinshi Pharm Carbocisteine Business Overview
- 4.4.3 Jinshi Pharm Carbocisteine Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Jinshi Pharm Product Portfolio
- 4.4.5 Jinshi Pharm Recent Developments
- 4.5 Hengkang Pharma
- 4.5.1 Hengkang Pharma Carbocisteine Company Information
- 4.5.2 Hengkang Pharma Carbocisteine Business Overview
- 4.5.3 Hengkang Pharma Carbocisteine Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Hengkang Pharma Product Portfolio
- 4.5.5 Hengkang Pharma Recent Developments
- 4.6 Globe Quimica
- 4.6.1 Globe Quimica Carbocisteine Company Information
- 4.6.2 Globe Quimica Carbocisteine Business Overview
- 4.6.3 Globe Quimica Carbocisteine Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Globe Quimica Product Portfolio
- 4.6.5 Globe Quimica Recent Developments
- 4.7 Xiangyu Pharmaceutical
- 4.7.1 Xiangyu Pharmaceutical Carbocisteine Company Information
- 4.7.2 Xiangyu Pharmaceutical Carbocisteine Business Overview
- 4.7.3 Xiangyu Pharmaceutical Carbocisteine Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Xiangyu Pharmaceutical Product Portfolio
- 4.7.5 Xiangyu Pharmaceutical Recent Developments
5 Global Carbocisteine Production by Region
- 5.1 Global Carbocisteine Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Carbocisteine Production by Region: 2021-2032
- 5.2.1 Global Carbocisteine Production by Region: 2021-2026
- 5.2.2 Global Carbocisteine Production Forecast by Region (2027-2032)
- 5.3 Global Carbocisteine Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Carbocisteine Production Value by Region: 2021-2032
- 5.4.1 Global Carbocisteine Production Value by Region: 2021-2026
- 5.4.2 Global Carbocisteine Production Value Forecast by Region (2027-2032)
- 5.5 Global Carbocisteine Market Price Analysis by Region (2021-2026)
- 5.6 Global Carbocisteine Production and Value, YOY Growth
- 5.6.1 North America Carbocisteine Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Carbocisteine Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Carbocisteine Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Carbocisteine Production Value Estimates and Forecasts (2021-2032)
6 Global Carbocisteine Consumption by Region
- 6.1 Global Carbocisteine Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Carbocisteine Consumption by Region (2021-2032)
- 6.2.1 Global Carbocisteine Consumption by Region: 2021-2026
- 6.2.2 Global Carbocisteine Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Carbocisteine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Carbocisteine Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Carbocisteine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Carbocisteine Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Carbocisteine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Carbocisteine Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Carbocisteine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Carbocisteine Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Carbocisteine Production by Type (2021-2032)
- 7.1.1 Global Carbocisteine Production by Type (2021-2032) & (MT)
- 7.1.2 Global Carbocisteine Production Market Share by Type (2021-2032)
- 7.2 Global Carbocisteine Production Value by Type (2021-2032)
- 7.2.1 Global Carbocisteine Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Carbocisteine Production Value Market Share by Type (2021-2032)
- 7.3 Global Carbocisteine Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Carbocisteine Production by Application (2021-2032)
- 8.1.1 Global Carbocisteine Production by Application (2021-2032) & (MT)
- 8.1.2 Global Carbocisteine Production Market Share by Application (2021-2032)
- 8.2 Global Carbocisteine Production Value by Application (2021-2032)
- 8.2.1 Global Carbocisteine Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Carbocisteine Production Value Market Share by Application (2021-2032)
- 8.3 Global Carbocisteine Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Carbocisteine Value Chain Analysis
- 9.1.1 Carbocisteine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Carbocisteine Production Mode & Process
- 9.2 Carbocisteine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Carbocisteine Distributors
- 9.2.3 Carbocisteine Customers
10 Global Carbocisteine Analyzing Market Dynamics
- 10.1 Carbocisteine Industry Trends
- 10.2 Carbocisteine Industry Drivers
- 10.3 Carbocisteine Industry Opportunities and Challenges
- 10.4 Carbocisteine Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst